Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Moss

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Medical Genetics. Part A|March 4, 2005
Novel contributions to the Asian CFTR mutation spectrum: Genotype and phenotype in Thai patients with cystic fibrosisIris Schrijver, Wikrom Karnsakul, Chanin Limwongse, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 25, 2012
Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycinJennifer Ruddy, Julia Emerson, Richard Moss, et al.
Respiratory Medicine|January 11, 2026
Peripheral Muscle Strength and Lung Function in Adults with Cystic FibrosisTaylor Lewis, Jacquelyn Spano, Jennifer Kwok, et al.
Annals of the New York Academy of Sciences|June 26, 2024
NPCC4: Concepts and tools for envisioning New York City's futuresDeborah Balk, Timon McPhearson, Elizabeth M Cook, et al.
Earth'S Future|July 12, 2024
Research to Confront Climate Change Complexity: Intersectionality, Integration, and Innovative GovernanceKatharine J Mach, Kripa Jagannathan, Linda Shi, et al.
Pediatric Pulmonology|May 31, 2007
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Nicole Mayer-Hamblett, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Sharon McNamara, et al.
Pancreas|April 22, 2006
Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patientsDrucy Borowitz, Christopher H Goss, Christopher Stevens, et al.
The New England Journal of Medicine|November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
Annals of the New York Academy of Sciences|August 19, 2024
NPCC4: Climate risk and equity-advancing knowledge toward a sustainable future | ConclusionsJoel Towers, Robin Leichenko, Christian Braneon, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Medical Genetics. Part A|March 4, 2005
Novel contributions to the Asian CFTR mutation spectrum: Genotype and phenotype in Thai patients with cystic fibrosisIris Schrijver, Wikrom Karnsakul, Chanin Limwongse, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 25, 2012
Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycinJennifer Ruddy, Julia Emerson, Richard Moss, et al.
Respiratory Medicine|January 11, 2026
Peripheral Muscle Strength and Lung Function in Adults with Cystic FibrosisTaylor Lewis, Jacquelyn Spano, Jennifer Kwok, et al.
Annals of the New York Academy of Sciences|June 26, 2024
NPCC4: Concepts and tools for envisioning New York City's futuresDeborah Balk, Timon McPhearson, Elizabeth M Cook, et al.
Earth'S Future|July 12, 2024
Research to Confront Climate Change Complexity: Intersectionality, Integration, and Innovative GovernanceKatharine J Mach, Kripa Jagannathan, Linda Shi, et al.
Pediatric Pulmonology|May 31, 2007
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Nicole Mayer-Hamblett, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Sharon McNamara, et al.
Pancreas|April 22, 2006
Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patientsDrucy Borowitz, Christopher H Goss, Christopher Stevens, et al.
The New England Journal of Medicine|November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
Annals of the New York Academy of Sciences|August 19, 2024
NPCC4: Climate risk and equity-advancing knowledge toward a sustainable future | ConclusionsJoel Towers, Robin Leichenko, Christian Braneon, et al.
Pageof 3